Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;6(1):10-14.
doi: 10.15171/jnp.2017.03. Epub 2016 Aug 14.

Effect of Vitamin D on Proteinuria in Type 2 Diabetic Patients

Free PMC article

Effect of Vitamin D on Proteinuria in Type 2 Diabetic Patients

Ali Momeni et al. J Nephropathol. .
Free PMC article


Background: Vitamin D (Vit D) deficiency is a common disorder in diabetic patients and may be a risk factor for ischemic heart disease and exacerbation of diabetic nephropathy(DN).

Objectives: The aim of this study was to evaluate the effect of Vit D3 therapy on protein uriain type 2 diabetic patients with deficient or insufficient serum Vit D.

Patients and methods: In a double blind clinical trial, 60 type 2 diabetic patients with proteinuria greater than 150 mg/day who had Vit D deficiency or insufficiency were randomly enrolled in two equal groups. Pearl of Vit D as 50 000 IU/week and placebo (1 tablet per week) were prescribed in patients of case and control groups respectively for 8 weeks. At the beginning and 2 months later, 24 hours urine protein was checked in all patients.

Results: There is no difference between serums Vit D level in case and control group at the beginning of the study, however at the end of the study serum Vit D level was significantly higher in the case group. There is no difference in proteinuria between case and control group at the beginning and the end of the study, while a significant difference between the changes of proteinuria before and after the study was seen in two groups (P = 0.028).

Conclusions: Vit D deficiency may exacerbate protein uric and DN, hence correction of Vit D deficiency may decrease proteinuria in diabetic patients with nephropathy.

Keywords: Diabetes mellitus; Diabetic nephropathy; Proteinuria; Vitamin D.


Figure 1
Figure 1

Similar articles

See all similar articles

Cited by 4 articles


    1. Geiss LS, Wang J, Cheng YJ, Thompson TJ, Barker L, Li Y. et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA. 2014;312(12):1218–26. doi: 10.1001/jama201411494. - DOI - PubMed
    1. Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gilbertson D. et al. Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis. 2007;49(1 Suppl 1):A6–7. doi: 10.1053/j.ajkd.2006.11.019. - DOI - PubMed
    1. Jacob AN, Khuder S, Malhotra N, Sodeman T, Gold JP, Malhotra D. et al. Neural network analysis to predict mortality in end-stage renal disease: application to United States Renal Data System. Nephron Clin Pract. 2010;116(2):c148–58. doi: 10.1159/000315884. - DOI - PubMed
    1. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 1999;341(15):1127–33. doi: 10.1056/NEJM199910073411506. - DOI - PubMed
    1. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28(1):164–76. doi: 10.2337/diacare.28.1.164. - DOI - PubMed

LinkOut - more resources